Annual Non Current Assets
$67.54 M
+$1.04 M+1.56%
31 December 2023
Summary:
Monte Rosa Therapeutics annual long term assets is currently $67.54 million, with the most recent change of +$1.04 million (+1.56%) on 31 December 2023. During the last 3 years, it has risen by +$61.76 million (+1067.15%). GLUE annual non current assets is now at all-time high.GLUE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$63.87 M
-$2.35 M-3.54%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly long term assets is currently $63.87 million, with the most recent change of -$2.35 million (-3.54%) on 30 September 2024. Over the past year, it has dropped by -$5.32 million (-7.69%). GLUE quarterly non current assets is now -9.42% below its all-time high of $70.51 million, reached on 30 June 2023.GLUE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | -7.7% |
| 3 y3 years | +1067.2% | +372.1% |
| 5 y5 years | - | - |
GLUE Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1067.2% | -9.4% | +372.1% |
| 5 y | 5 years | at high | +4959.4% | -9.4% | +1003.7% |
| alltime | all time | at high | +4959.4% | -9.4% | +1003.7% |
Monte Rosa Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $63.87 M(-3.5%) |
| June 2024 | - | $66.22 M(-2.2%) |
| Mar 2024 | - | $67.71 M(+0.2%) |
| Dec 2023 | $236.21 M(-14.4%) | $67.54 M(-2.4%) |
| Sept 2023 | - | $69.19 M(-1.9%) |
| June 2023 | - | $70.51 M(+3.0%) |
| Mar 2023 | - | $68.47 M(+3.0%) |
| Dec 2022 | $275.89 M | $66.50 M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $62.37 M(-8.3%) |
| June 2022 | - | $68.01 M(+165.3%) |
| Mar 2022 | - | $25.64 M(+45.2%) |
| Dec 2021 | $348.67 M(+699.9%) | $17.66 M(+30.5%) |
| Sept 2021 | - | $13.53 M(+27.0%) |
| June 2021 | - | $10.65 M(+19.7%) |
| Mar 2021 | - | $8.90 M(+53.7%) |
| Dec 2020 | $43.59 M(+346.7%) | $5.79 M |
| Dec 2019 | $9.76 M | - |
FAQ
- What is Monte Rosa Therapeutics annual long term assets?
- What is the all time high annual non current assets for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual non current assets year-on-year change?
- What is Monte Rosa Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly non current assets year-on-year change?
What is Monte Rosa Therapeutics annual long term assets?
The current annual non current assets of GLUE is $67.54 M
What is the all time high annual non current assets for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual long term assets is $67.54 M
What is Monte Rosa Therapeutics annual non current assets year-on-year change?
Over the past year, GLUE annual long term assets has changed by +$1.04 M (+1.56%)
What is Monte Rosa Therapeutics quarterly long term assets?
The current quarterly non current assets of GLUE is $63.87 M
What is the all time high quarterly non current assets for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly long term assets is $70.51 M
What is Monte Rosa Therapeutics quarterly non current assets year-on-year change?
Over the past year, GLUE quarterly long term assets has changed by -$5.32 M (-7.69%)